MetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Boston, Massachusetts. The company went IPO on 2008-02-13. The firm's therapeutic focus targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. The firm's product development programs are focused on developing drug candidates and companion diagnostic tests that target the MENA pathway. Its pipelines include MENA Diagnostic Assay and MetaSite Breast Assay. The MENA diagnostic assay is a tissue-based quantitative immunofluorescence (QIF) test that measures expression of the pro-metastatic MENA protein splice-variant which is associated with poor outcomes and metastasis in early-stage breast cancer (ESBC) and squamous cell carcinoma of the Lung. MetaSite Breast is an immunohistochemistry test (IHC) that measures micro-anatomical intravasation sites (TMEM) at blood vessels within the tumor microenvironment which are clinically validated as prognostic markers of metastasis in hormone receptor-positive (HR+) ESBC.
MTST stock price ended at $0 on Monday, after rising NaN%
On the latest trading day Dec 29, 2025, the stock price of MTST rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 4.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 7.5K shares were traded, equating to a market value of approximately --.
MTST Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
MTST currently exhibits 0 buy signals and 0 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for MTST
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for MTST. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to MTST?
According to technical analysis, MetaStat Inc has an aggregate signal of Neutral. MetaStat Inc has 0 Buy signals, 7 Neutral Signals and 0 sell signals.
What are the Fibonacci retracement levels for MTST?
The Fibonacci retracement level for MetaStat Inc is between 78.6% and 100%
What is the RSI for MetaStat Inc?
The RSI for MetaStat Inc is currently NaN, indicating a neutral condition
What is MetaStat Inc price for the next 12 months?
MetaStat Inc MTST price for the next 12 months is estimated at $0.
How high is MetaStat Inc expected to go?
According to wall street analysts, MetaStat Inc is expected to reach a high forecast of $0.